CDH1 and central nervous system cancer: Consistent with the cellular behaviors, molecular changes related to mesenchymal transition were also reversed, characterized by decreased expression of Vimentin and N-cadherin, and increased expression of E-cadherin in glioma cells when GPR65 was inhibited (Figs. 5G & S5H-I).